Comparison of Three Different FDA-Approved Plasma HIV-1 RNA Assay Platforms Confirms the Virologic Failure Endpoint of 200 Copies Per Milliliter Despite Improved Assay Sensitivity

Journal of Clinical Microbiology - United States
doi 10.1128/jcm.00801-15

Related search